L
Linghong Chen
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 5
Citations - 1303
Linghong Chen is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Neuropathology & Alzheimer's disease. The author has an hindex of 4, co-authored 5 publications receiving 1199 citations.
Papers
More filters
Journal ArticleDOI
Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction
Weiping Qin,Tianle Yang,Lap Ho,Lap Ho,Zhong Zhao,Jun Wang,Linghong Chen,Wei Zhao,Meenakshisundaram Thiyagarajan,Donal MacGrogan,Joseph T. Rodgers,Pere Puigserver,Junichi Sadoshima,Haiteng Deng,Steven Pedrini,Sam Gandy,Anthony A. Sauve,Giulio Maria Pasinetti,Giulio Maria Pasinetti +18 more
TL;DR: The predicted attenuation ofβ-amyloid content in the brain during CR can be reproduced in mouse neurons in vitro by manipulating cellular SIRT1 expression/activity through mechanisms involving the regulation of the serine/threonine Rho kinase ROCK1.
Journal ArticleDOI
Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.
Jun Wang,Lap Ho,Wei Zhao,Kenjiro Ono,Clark Rosensweig,Linghong Chen,Nelson Humala,David B. Teplow,Giulio Maria Pasinetti +8 more
TL;DR: It is found that a naturally derived grape seed polyphenolic extract can significantly inhibit amyloid β-protein aggregation into high-molecular-weight oligomers in vitro and suggests that grape seed-derived polyphenolics may be useful agents to prevent or treat AD.
Journal ArticleDOI
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang,Lap Ho,Linghong Chen,Zhong Zhao,Wei Zhao,Xianjuan Qian,Nelson Humala,Ilana Seror,Sadie Bartholomew,Clive Rosendorff,Giulio Maria Pasinetti +10 more
TL;DR: In this article, the authors identified 7 candidate antihypertensive agents that significantly reduced AD-type beta-amyloid protein (Abeta) accumulation and attenuated the development of Abeta-mediated cognitive deterioration, even when delivered at a dose about 2-fold lower than that used for hypertension treatment in humans.
Book ChapterDOI
Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications.
Giulio Maria Pasinetti,Zhong Zhao,Weiping Qin,Lap Ho,Yemul Shrishailam,Donal MacGrogan,Wendy Ressmann,Nelson Humala,Xunxian Liu,Carmen Romero,Breton Stetka,Linghong Chen,Hanna Ksiezak-Reding,Jun Wang +13 more
TL;DR: While it is found that high caloric intake based on saturated fat promotes AD type Beta-amyloidosis, conversely, dietary restriction based on reduced carbohydrate intake is able to prevent it, this evidence is very exciting and is consistent with current epidemiological studies suggesting that obesity and diabetes are associated with a >4-fold increased risk of developing AD.